Eisai
4523.T
#2012
Rank
S$10.78 B
Marketcap
$38.25
Share price
0.12%
Change (1 day)
-42.51%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of March 2024 : S$1.42 Billion

According to Eisai's latest financial reports the company's total debt is S$1.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-03-31S$1.25 B19.52%
2022-03-31S$1.05 B-4.19%
2021-03-31S$1.09 B-7.38%
2020-03-31S$1.18 B-30.11%
2019-03-31S$1.69 B-20.53%
2018-03-31S$2.13 B-20.02%
2017-03-31S$2.66 B9%
2016-03-31S$2.44 B-9.54%
2015-03-31S$2.70 B-10.56%
2014-03-31S$3.02 B-26.77%
2013-03-31S$4.13 B-21.09%
2012-03-31S$5.23 B-9.1%
2011-03-31S$5.76 B-6.04%
2010-03-31S$6.13 B-5.42%
2009-03-31S$6.48 B13.51%
2008-03-31S$5.71 B187741.19%
2007-03-31S$3.04 M-46.34%
2006-03-31S$5.66 M-55.89%
2005-03-31S$12.84 M318.59%
2004-03-31S$3.06 M485.92%
2003-03-31S$0.52 M-99.42%
2002-03-31S$90.53 M-20.22%
2001-03-31S$0.11 B-62.38%
2000-03-31S$0.30 B